Multiple doses of contrast medium from a single container: bacteriological studies.
Preparations of Iopromide (Ultravist 370; Schering Pty Ltd, Sydney, NSW, Australia), brain/heart infusion broth (BHI; positive growth control) and distilled water (negative control) were inoculated with 10(3) to 10(4) Pseudomonas aeruginosa, Escherichia coli or Staphylococcus aureus cells and incubated at 37 degrees C. Slow decreases (up to one log) were observed in each organism's count in Iopromide and distilled water at room temperature and in S. aureus and E. coli in Iopromide and distilled water at 35 degrees C until 6-8 h, when counts stabilized. BHI cultures showed logarithmic increases. P. aeruginosa counts increased (half log over 8 h) in Ultravist at 37 degrees C. Radiology laboratories were shown to have similar airborne bacterial loads to operating theatres. Samples from repeatedly entered Iopromide bottles showed no contamination. Multiple intravenous doses from a single bottle of non-ionic contrast medium can safely be used as a cost-saving measure provided scrupulous attention is paid to aseptic preparation. Unused decanted contrast medium should be discarded after 4 h.
University of Melbourne Department of Radiology, Royal Melbourne Hospital, Parkville, Vic., Australia.
B M
BM
Tress
A G
AG
Hellyar
J
J
Pennington
K R
KR
Thomson
P M
PM
Desmond
J
J
Martinkus
J J
JJ
Lavan
D001419:Bacteria / Q000302:isolation & purification*; D003287:Contrast Media / Q000008:administration & dosage*; D004340:Drug Contamination; D004349:Drug Packaging; D004783:Environmental Microbiology; D006801:Humans; D007275:Injections, Intravenous; D007472:Iohexol / Q000008:administration & dosage / Q000031:analogs & derivatives
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide